Strumento inattivo

Altre lingue Orchid Pharma Limited Bombay S.E.

Azioni

524372

INE191A01019

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	06/06
Orchid Pharma Receives DCGI Approval for Its First Invented and Made-In-India Antibiotic Drug Combination of Cefepime and Enmetazobactam	06/06
Orchid Pharma Limited Appoints Shubha Singh as Additional Director	23/05
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	23/05
PUFE Transactions Under IBC	14/05
Orchid Pharma Limited Receives Order from Office of Assistant Commissioner Valluvarkottam Central-III Chennai Central	02/05
Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	12/04
Orchid Pharma : Iii. Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023	12/04
Orchid Pharma : Un-audited Financial Results for the quarter ended June 30, 2023 - June 30,2023	12/04
Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023	12/04
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	23/02
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	30/01
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	16/12
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	14/12
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	20/10/23
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections	12/09/23
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	12/09/23
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Orchid Pharma Limited Bombay S.E.

Azioni

524372

INE191A01019

Altre lingue

Filtri